Literature DB >> 6685203

Loss of selectivity of Warren shunt in long-term observation.

T Isomatsu.   

Abstract

Sixty patients who underwent distal splenorenal shunt were followed up from one to ten years, with an average of 5.6 years. Postoperative portography through the superior mesenteric artery was carried out in 58 of these patients and the remaining two were studied at autopsy. The diameter of the portal vein was unchanged in 65 per cent of the patients within 30 postoperative days, but it decreased remarkably in size one year after the surgery in one third of the patients, and it was observed in about half of the patients at 5 years after the surgery. Numerous collaterals had developed around the pancreas and stomach in the majority of cases presenting narrowing of the portal vein. Enormously dilated pancreatic veins directed to non-isolated distal splenic vein were identified in the autopsied cases. These findings strongly suggest that pancreatic veins connecting to the distal vein may play a leading role in production of malcirculation of the portal system after distal splenorenal shunt.

Entities:  

Mesh:

Year:  1983        PMID: 6685203     DOI: 10.1007/bf02469477

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  6 in total

1.  Thrombosis of the portal vein following distal splenorenal shunt.

Authors:  L E Rotstein; L Makowka; B Langer; L M Blendis; R M Stone; R F Colapinto
Journal:  Surg Gynecol Obstet       Date:  1979-12

2.  Selectivity of the distal splenorenal shunt.

Authors:  J N Maillard; Y M Flamant; J M Hay; J G Chandler
Journal:  Surgery       Date:  1979-11       Impact factor: 3.982

3.  Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism.

Authors:  A Marni; C Trojsi; L Belli
Journal:  Am J Surg       Date:  1981-09       Impact factor: 2.565

4.  Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt.

Authors:  W D Warren; R Zeppa; J J Fomon
Journal:  Ann Surg       Date:  1967-09       Impact factor: 12.969

5.  The incidence and natural history of thrombus in the portal vein following distal splenorenal shunt.

Authors:  J M Henderson; W J Millikan; J Chipponi; L Wright; P J Sones; L Meier; W D Warren
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

6.  Ten years portal hypertensive surgery at Emory. Results and new perspectives.

Authors:  W D Warren; W J Millikan; J M Henderson; L Wright; M Kutner; R B Smith; J T Fulenwider; A A Salam; J T Galambos
Journal:  Ann Surg       Date:  1982-05       Impact factor: 12.969

  6 in total
  6 in total

1.  [Hepatic encephalopathy after portosystemic shunt].

Authors:  D Jentschura; L W Storz; B Rumstadt; M Winkler
Journal:  Langenbecks Arch Chir       Date:  1996

2.  Distal splenorenal shunt with splenopancreatic disconnection. A 4-year assessment.

Authors:  J M Henderson; W D Warren; W J Millikan; J R Galloway; S Kawasaki; M H Kutner
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

3.  A method of measuring quantitative hepatic function and hemodynamics in cirrhosis: the changes following distal splenorenal shunt.

Authors:  J M Henderson; W D Warren
Journal:  Jpn J Surg       Date:  1986-05

4.  Exclusion of nonisolated splenic vein in distal splenorenal shunt for prevention of portal malcirculation.

Authors:  K Inokuchi; K Beppu; N Koyanagi; K Nagamine; M Hashizume; K Sugimachi
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

5.  Successful surgical treatment for hepatic encephalopathy caused by a pancreatic siphon: report of a case.

Authors:  H Nozaki; T Shimada; Y Fukushima; T Inou; Y Takeda
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

6.  Should both schistosomal and nonschistosomal variceal bleeders be disconnected?

Authors:  K M Abu-Elmagd; F A Ezzat; O M Fathy; N A el-Ghawlby; M A Aly; A M el-Fiky; M H el-Barbary; G E el-Ebady; N G el-Hak
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.